Local Institution - 0005
Santiago, Santiago Metropolitan 7500921
1 studies enrolling now · 2 studies all time
What they study most
Clear Cell Renal Cell Carcinoma, Non-Small Cell Lung Cancer
Studies at this site
- Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01) — Recruiting now
- A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread — Running, not enrolling